CTL

BIOLOGICAL4 trials

Sponsors

University of Lausanne, The First People's Hospital of Changzhou, Tianjin Medical University Cancer Institute and Hospital, The Second Hospital of Shandong University

Conditions

Gastric CancerHepatic SteatosisNon-small Cell Lung CancerSecond-line Treatment

Phase 1

Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer

Active, not recruitingNCT02496273

The First People's Hospital of ChangzhouGastric Cancer

Start: 2016-01-31End: 2030-12-31Target: 60Updated: 2016-02-22

Study of Autologous Cytotoxic T Lymphocyte Immunotherapy Combination With PD-1 Inhibitor in the Advanced NSCLC

Tianjin Medical University Cancer Institute and HospitalNon-small Cell Lung Cancer, Second-line Treatment

Start: 2019-06-01End: 2021-06-01Target: 10Updated: 2020-07-07

Safety and Efficacy Study for MG-7-DC Vaccine in Gastric Cancer Treatment

The Second Hospital of Shandong UniversityGastric Cancer

Start: 2020-09-30End: 2022-06-30Target: 45Updated: 2020-09-28

Unknown Phase

Effects of Coffee on Hepatic Steatosis Induced by a High Fructose Diet

CompletedNCT00827450

University of LausanneHepatic Steatosis

Start: 2009-02-28End: 2011-03-31Updated: 2012-02-24

Related Papers

A single-arm phase Ib study of personalized peptide-pulsed dendritic cell-based multiple target cytotoxic T lymphocyte immunotherapy in combination with toripalimab as second-line therapy in advanced non-small-cell lung cancer

Cancer Immunology Immunotherapy2026-03-11

A single-arm phase Ib study of multiple target cytotoxic T-lymphocyte (MCTL) in combination with toripalimab as second-line therapy in advanced non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology2021-05-201 citations

Coffee consumption attenuates short-term fructose-induced liver insulin resistance in healthy men.

2013-11-2064 citations